Ocumension Therapeutics Stock OTC Markets
Stocks
OCUTF
KYG674111011
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7000 USD | -.--% |
|
-.--% | - |
| 07-03 | Ocumension Therapeutics Wins China Nod for Eye Inflammation Drug | MT |
| 07-02 | Ocumension Therapeutics New Drug Application of Ot-502 Approved by the National Medical Products Administration | CI |
| Market Cap | 3.65B 538M 472M 437M 402M 760M 51.46B 775M 5.21B 2.04B 25.27B 2.02B 1.97B 87.28B | P/E 2026 * |
112x | P/E 2027 * | 30.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.45B 510M 447M 414M 381M 720M 48.77B 734M 4.93B 1.93B 23.95B 1.91B 1.87B 82.7B | EV / Sales 2026 * |
3.13x | EV / Sales 2027 * | 2.52x |
| Free-Float |
39.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Current year | 0.7 |  | 0.7 |
| 1 year | 0.7 | | 0.7 |
| 3 years | 0.7 | | 0.7 |
| 5 years | 0.7 | | 0.7 |
| 10 years | 0.7 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ye Liu
CEO | Chief Executive Officer | 54 | 2018-07-31 |
Yang Shen
CTO | Chief Tech/Sci/R&D Officer | 43 | 2023-12-31 |
Zhao Peng Hu
LAW | General Counsel | 53 | 2018-09-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Ye Liu
BRD | Director/Board Member | 54 | 2018-11-22 |
Zhao Peng Hu
BRD | Director/Board Member | 53 | 2020-04-23 |
Yan Ling Cao
BRD | Director/Board Member | 42 | 2019-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 527M | |
| -0.09% | -1.25% | +48.26% | +172.63% | 1,060B | |
| +0.43% | -0.58% | +64.41% | +62.35% | 619B | |
| -0.51% | -3.06% | +28.95% | +84.87% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -1.14% | -2.08% | +20.80% | +57.60% | 196B | |
| +0.85% | +1.10% | +16.91% | +70.83% | 161B | |
| Average | -0.25% | -3.33% | +25.37% | +55.91% | 397.1B | |
| Weighted average by Cap. | -0.22% | -3.10% | +35.58% | +84.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1B 163M 143M 132M 122M 230M 15.59B 235M 1.58B 619M 7.66B 612M 598M 26.44B | 1.42B 210M 184M 171M 157M 297M 20.11B 303M 2.03B 798M 9.87B 789M 772M 34.1B |
| Net income | 31.83M 4.69M 4.12M 3.81M 3.51M 6.64M 449M 6.77M 45.45M 17.83M 221M 17.63M 17.24M 762M | 122M 17.92M 15.72M 14.56M 13.4M 25.34M 1.72B 25.83M 174M 68.06M 842M 67.3M 65.83M 2.91B |
| Net Debt | -191M -28.18M -24.71M -22.89M -21.06M -39.83M -2.7B -40.61M -273M -107M -1.32B -106M -103M -4.57B | -51.13M -7.54M -6.61M -6.13M -5.64M -10.66M -722M -10.87M -73.01M -28.64M -354M -28.32M -27.7M -1.22B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1477 Stock
- OCUTF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
